Its the same attitude we have been getting from wall street the entire ph 2a, + extensions. If someone questions the study or trial than they should contact the FDA because they designed the trial and Anavex is simply following their design.....which is unprecedented I might add. All I'm saying is their may be a change in protocol in the wind from the old way of thinking with respect to placebo controlled trials being needed before approval. It would be fine to do a ph 3 and/or ph 4, Heck!..... placebo the hell out of it but their is no reason why patients should not be allowed access to a SAFE drug that BLOWS away SOC by leaps and bounds once a optimized dose is found all of which I believe the FDA is looking Dr. Missling at as we speak.
News 
Market Data 
Discover 
